Articles From: Amgen Announces Phase 3 ASPIRE Trial Of Kyprolis® In Patients With Relapsed Multiple Myeloma Met Primary Endpoint to Symmetry Medical Reports Second Quarter 2014 Financial Results


Kyprolis Helped Patients Live 8.7 Months Longer Without Their Disease Worsening Results to Form Basis of Regulatory Filings Beginning in 1H 2015 THOUSAND OAKS, Calif.
Sign-up for Amgen Announces Phase 3 ASPIRE Trial Of Kyprolis® In Patients With Relapsed Multiple Myeloma Met Primary Endpoint investment picks
2014/8/4
- Interest rate volume rose 25 percent - Eurodollar futures volume increased 40 percent and Eurodollar options volume increased 38 percent - Open interest surpassed 100 million contracts and is up 20 percent year-to-date in 2014 CHICAGO , Aug.
Sign-up for CME Group Volume Averaged 12.2 Million Contracts per Day in July 2014, Up 13 Percent from July 2013 investment picks
CGI's proprietary genomic test has been CLIA and NYS licensed to stratify CLL and SLL patient into three distinct outcome groups: favorable, intermediate, and unfavorable It is the only comprehensive test to report on 20 clinically-validated and disease-relevant genomic regions focused on CLL and SLL The proprietary genomic test addresses a growing market of over 120,000 patients for the most common form of leukemia (CLL/SLL) RUTHERFORD, N.J., Aug.
Sign-up for Cancer Genetics, Inc. Releases the Only Comprehensive Genomic Test to Diagnose & Stratify the Most Common Form of Leukemia (CLL) investment picks
BRENTWOOD, Tenn., Aug.
Sign-up for Diversicare Announces the Acquisition of Operations of Two Facilities in Ohio investment picks
WALTHAM, Mass.
Sign-up for Alere Inc. Announces Second Quarter 2014 Results investment picks
2014/8/4
Intelsat S.A. (NYSE: I), the world’s leading provider of satellite services, today reported total revenue of $615.7 million and net income attributable to Intelsat S.A. of $66.8 million, or $0.53 per common share on a diluted basis, for the three months ended June 30, 2014.
Sign-up for Intelsat Reports Second Quarter 2014 Results investment picks
AZOUR, Israel , August 4, 2014 /PRNewswire/ -- Ituran Location and Control Ltd.
Sign-up for Ituran Location and Control Announces Receipt of 2010-2012 Tax Assessments From the Israeli Tax Authority investment picks
2014/8/4
OWINGS MILLS, Md., Aug.
Sign-up for Universal Security Instruments Announces the Filing of its Form 10-K and Reports Fourth-Quarter and Year-End Results investment picks
FitLife Brands, Inc. (OTCBB:FTLF), an international provider of innovative and proprietary nutritional supplements for health conscious consumers marketed under the brand names NDS Nutrition Products™ (“NDS”) ( www.ndsnutrition.com ), PMD® ( www.pmdsports.com ), SirenLabs® ( www.sirenlabs.com ) and CoreActive® ( www.coreactivenutrition.com ) today announced it will release its second quarter 2014 financial results for the period ended June 30, 2014 after the market closes on Thursday, August 7, 2014.
Sign-up for FitLife Brands to Announce Second Quarter 2014 Financial Results investment picks
Cytori Therapeutics (NASDAQ: CYTX) will provide a live webcast of its second quarter financial results and business update on Monday, August 11, 2014 at 5:00 PM Eastern Time.
Sign-up for Cytori to Webcast Second Quarter Financial Results on August 11 investment picks
BURLINGTON, Mass., Aug.
Sign-up for Aldeyra Therapeutics Reports Second Quarter 2014 Financial Results investment picks
Vanguard Natural Resources, LLC (NASDAQ: VNR) (“Vanguard” or “the Company”) today announced it has entered into a definitive agreement to acquire natural gas, oil and natural gas liquids (“NGLs”) assets in North Louisiana and East Texas for a purchase price of $278 million from Hunt Oil Company.
Sign-up for Vanguard Natural Resources, LLC Signs Agreement to Acquire Properties in North Louisiana and East Texas investment picks
LONDON , Aug.
Sign-up for Noble Corporation Completes Spin-Off Of Paragon Offshore investment picks
TransAct Technologies Incorporated (Nasdaq:TACT), a global leader in market-specific solutions, including printers, terminals, software and other products for transaction-based and other industries, announced today that its Board of Directors has declared a quarterly cash dividend of $0.08 per share.
Sign-up for Transact Technologies Declares Quarterly Cash Dividend of $0.08 Per Share investment picks
Insmed Incorporated (Nasdaq: INSM) today announced that, following discussions with European regulatory authorities, it intends to file by the end of 2014 a Marketing Authorization Application (MAA) with the European Medicines Agency (EMA) for ARIKAYCE™, or liposomal amikacin for inhalation, for the treatment of nontuberculous mycobacteria (NTM) lung infections in treatment refractory patients as well as for Pseudomonas aeruginosa lung infections in cystic fibrosis (CF) patients.
Sign-up for Insmed Provides Regulatory Update for ARIKAYCE investment picks
2014/8/4
- Reported retail new vehicle unit sales in July 2014 increased 8% versus July 2013 FORT LAUDERDALE, Fla.
Sign-up for AutoNation Announces Reported Retail Sales of 27,484 New Vehicles in July 2014, Best July Since 2006(1) investment picks
http://media.marketwire.com/attachments/200911/587742_279192_BroadSoft_logo_2C.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1135032&ProfileId=051205&sourceType=1 GAITHERSBURG, MD --
Sign-up for BroadSoft Extends Unified Communications Services to the Hospitality Industry With the Acquisition of SDD investment picks
HONG KONG, Aug.
Sign-up for CMGE Obtained Rights to Develop Mobile Games on Shaolin Theme investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1135105&ProfileId=051205&sourceType=1 FORT MYERS, FL --
Sign-up for Yippy, Inc. (YIPI) Expands Executive Staff With CTO investment picks
2014/8/4
AMSTERDAM, the Netherlands, and PARMA, Italy, Aug.
Sign-up for Chiesi and uniQure Provide Update on Glybera(r) Launch investment picks
NEW YORK (MarketWatch) -- Cardinal Health Inc. (CAH) said it earned $234 million, or 68 cents a share, in its fiscal fourth quarter, after a loss of $586 million, or $1.72 a share, in the same period a year ago when it booked a goodwill impairment charge relating to its nuclear division.
Sign-up for Cardinal Health tops profit, sales estimates investment picks
Residential Real Estate Leader Reports Quarterly Revenue of $1.5 Billion Homesale Transaction Volume Increased 3% Year-over-Year MADISON, N.J. , Aug.
Sign-up for Realogy Reports Financial Results For Second Quarter 2014 investment picks
2014/8/4
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1135186&ProfileId=051205&sourceType=1 DENVER, CO --
Sign-up for Latteno's Rx Harvest Collective Acquires S. Orange County MMJ Delivery Service investment picks
2014/8/4
http://media.marketwire.com/attachments/201309/187840_jcm_logo_300dpi_RGB.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1135106&ProfileId=051205&sourceType=1 LAS VEGAS, NV --
Sign-up for JCM Enters Into Definitive Agreement to Acquire FutureLogic, Adding to Peripheral Product Portfolio investment picks
WILMINGTON, Mass.
Sign-up for Tecomet to Acquire Symmetry Medical Inc.'s OEM Solutions Business investment picks
Second Quarter Highlights: Revenue of $101.3 million, up 2.3% year-over-year Loss from continuing operations of $(2.6) million; as adjusted income from continuing operations of $6.4 million Loss per share from continuing operations of $(0.07); as adjusted earnings per share from continuing operations of $0.17 Debt leverage at 3.01 times as adjusted LTM EBITDA WARSAW, Ind., Aug.
Sign-up for Symmetry Medical Reports Second Quarter 2014 Financial Results investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Amgen Announces Phase 3 ASPIRE Trial Of Kyprolis® In Patients With Relapsed Multiple Myeloma Met Primary Endpoint to Symmetry Medical Reports Second Quarter 2014 Financial Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices